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Summary
The formation and plasticity of synaptic connections
rely on regulatory interactions between pre- and post-
synaptic cells. We show that the Drosophila heparan
sulfate proteoglycans (HSPGs) Syndecan (Sdc) and
Dallylike (Dlp) are synaptic proteins necessary to con-
trol distinct aspects of synaptic biology. Sdc promotes
the growth of presynaptic terminals, whereas Dlp reg-
ulates active zone form and function. Both Sdc andDlp
bind at high affinity to the protein tyrosine phospha-
tase LAR, a conserved receptor that controls both
NMJ growth and active zone morphogenesis. These
data and doublemutant assays showing a requirement
of LAR for actions of both HSPGs lead to a model in
which presynaptic LAR is under complex control,
with Sdc promoting and Dlp inhibiting LAR in order
to control synapse morphogenesis and function.
Introduction
The neuronal synapse is a specialized intercellular junc-
tion, the morphogenesis of which is vital for the function
and plasticity of neural circuits. At the cell surface, mul-
tiple cell and substrate adhesion molecules work with
each other and with extracellular matrix (ECM) proteins
*Correspondence: davie@hms.harvard.edu
5 These authors contributed equally to this work.
6 Present address: Department of Biology and Program in Neurosci-
ence, Pomona College, Claremont, California 91711.
7 Present address: NemaRx Pharmaceuticals Inc., #4, 3535 Re-
search Rd. NW, Calgary Alberta, Canada T2L 2K8.to maintain the physical bond between neuron and tar-
get and to regulate synapse form and function (reviewed
by Yamagata et al. [2003]).
One class of ECM molecule particularly important for
neuronal connectivity development is the heparan sul-
fate proteoglycans (HSPGs) (reviewed by Van Vactor
et al. [2006] and Yamaguchi [2001]). Heparan sulfate
(HS) is composed of a repeating dissaccaride unit (glu-
curonic acid and N-acetyl-glucosamine), which is then
modified by deacetylation, epimerization, and sulfation
to provide anionic binding sites for a number of extracel-
lular partners (reviewed by Bernfield et al. [1999]).
Although the secreted HSPGs Agrin and Perlecan are
well known as regulators of synapse assembly at the
vertebrate neuromuscular junction, recent data suggest
that cell surface HSPGs may also be important for syn-
aptic development. Syndecan-2 localizes to multiple
classes of synapses in the mammalian hippocampus
(Hsueh and Sheng, 1999; Hsueh et al., 1998). Consistent
with the synaptic accumulation of Syndecan-2, treat-
ment of hippocampal tissue with heparinase to remove
HS prevents efficient long-term potentiation (LTP) in
CA1 pyramidal neurons, thus implicating HSPGs in syn-
aptic plasticity (Lauri et al., 1999). Because LTP has
been linked to morphological dynamics and maturation
of the dendritic spines that process hippocampal inputs,
it is particularly intriguing that misexpression of Synde-
can-2 can induce accelerated morphological maturation
of rat hippocampal dendritic spines in cell culture (Ethell
and Yamaguchi, 1999). This suggests that Syndecan
may play an important role in synaptic development
and/or plasticity. However, in vivo elimination of Synde-
can (or Syndecans) is needed to show the requirement
of this HSPG family at the synapse.
Although the genetic analysis of Syndecan function in
the mammalian central nervous system (CNS) is compli-
cated by the existence of several family members, a sin-
gle Syndecan gene (Sdc) is present in Drosophila
(Spring et al., 1994). Analysis of Sdc function inDrosoph-
ila has highlighted roles in axonal pathfinding (Johnson
et al., 2004; Rawson et al., 2005; Steigemann et al.,
2004; Fox and Zinn, 2005); however, the function of
Sdc at the synapse is unknown. By far the best-charac-
terized Drosophila synapse is the larval NMJ. Unlike ver-
tebrate and C. elegans NMJs, the Drosophila counter-
part is glutamatergic, analogous to the majority of
mammalian CNS excitatory synapses (Gramates and
Budnik, 1999). By larval hatching, nascent NMJs have
formed in the periphery that will grow extensively
throughout larval life (see Figure 1A for a schematic of
ventral muscles and motor nerves). At the latest stage
of larval development (third instar), presynaptic arbors
fan out extending multiple branches decorated with
many round synaptic varicosities (‘‘boutons’’) that con-
tain the active zones that organize glutamate release
(Figure 1B).
Another class of cell surface molecules involved in
synapse development is the receptor protein tyrosine
phosphatases (RPTPs) (reviewed by Johnson and Van
Vactor [2003]). LAR family RPTPs have been identified
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518Figure 1. Syndecan Localizes to the Dro-
sophila Neuromuscular Junction
(A and B) Diagrams of the ventral body-wall
muscles (numbered) and motor nerves from
the dorsal aspect of the Drosophila larva (A)
and the 6/7 neuromuscular junction (B). The
intersegmantal nerve b (red) projects to the
ventral longitudinal muscle group (gray);
muscles 6 and 7 (dark gray) are part of this
group and are dually innervated by the most
proximal branch (b). An individual synaptic
bouton showing the location of the subsyn-
aptic reticulum (SSR) and a representation
of the active zone are shown at right.
(C) Immunostaining with anti-HRP and anti-
Sdc antibodies at the 6/7 NMJ. Sdc is highly
concentrated at synaptic boutons (asterisks
in merge).
(D) Higher magnification shows that the ma-
jority of Sdc appears to exist in a halo sur-
rounding FasII.
(E) Sdc mutant larvae (SdcP/Df48,ubi-sara)
lack all detectable Sdc staining at the 6/7
NMJ.
(F) Dlp and Sdc immunoreactivity show high
degrees of overlap within NMJs at the muscle
6/7 cleft.
(G) Higher magnification images of terminal
boutons show that Dlp localizes to punctate
structures that are contained within the
broader Sdc distribution (arrowheads).
(H) Drosophila LAR (Dlar) localizes preferen-
tially to terminal boutons (D) and shows
a high degree of overlap with Sdc at the 6/7
NMJ.
(I and J) A single plane of optical section from
the confocal microscope allowed a linescan
(white line) of relative fluorescence intensity
to compare the Sdc and HRP epitopes. A
plot of the intensity data as a function of po-
sition is shown in (J).
(K) Immunostaining with anti-Sdc and anti-
FasII antibodies to the NMJ on muscles 12
and 13 shows that Sdc localizes preferentially
to type Is and Ib boutons (arrowhead) but is
absent from type II boutons (asterisks). Scale
bar in (E) represents 50 mm for (C), 5 mm for (D)
and (E), and 3 mm for (F).with roles in synapse formation inDrosophila (Kaufmann
et al., 2002), C. elegans (Ackley et al., 2005), and verte-
brates (Dunah et al., 2005). Although relatively few
RPTP-ligand interactions have been tested for function
in vivo, several molecules have been identified that
bind to LAR-family receptors, including Laminin-
Nidogen complexes and HSPGs. Although genetic
data implicate Nidogen in the synaptic LAR pathway of
C. elegans (Ackley et al., 2005), synaptic HSPG-LAR in-
teractions have not been tested in any organism.
In this study, we examine the synaptic functions of
two HSPGs in Drosophila: Syndecan (Sdc) and the gly-
cosylphosphatidyl-inositol (GPI) anchored glypican Dal-lylike (Dlp). We find that Sdc is required for normal levels
of morphological growth at the larval NMJ without obvi-
ous effects on the electrophysiology of the synapse. In
contrast, Dlp is necessary to regulate the form and phys-
iological function of active zones but plays no apparent
role in regulation of bouton addition. Becuase LAR-fam-
ily receptor protein tyrosine phosphatases have been
shown to bind HSPGs in different contexts (Aricescu
et al., 2002; Fox and Zinn, 2005), and because LAR reg-
ulates both NMJ growth and active zone structure in
Drosophila (Kaufmann et al., 2002), we asked if Sdc
and Dlp might function through interactions with LAR.
We find that both Sdc and Dlp bind to Drosophila LAR
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iments indicate that both Sdc and Dlp act upstream of
LAR. Our results reveal a complex regulatory relation-
ship between LAR and two HSPGs that control distinct
aspects of synapse biology, with Sdc acting to promote
LAR function and NMJ growth, and Dlp acting to antag-
onize LAR function and influence active zone structure
and physiology.
Results
Drosophila HSPGs Localize to
the Neuromuscular Junction
Syndecan-family HSPGs have been localized to verte-
brate glutamatergic synapses (Hsueh and Sheng,
1999; Hsueh et al., 1998); however, Sdc distribution at
analogous synapses in Drosophila was unknown. Using
confocal microscopy, we examined wild-type third in-
star larval fillets and compared the staining patterns of
antibodies against Drosophila Sdc, the presynaptic
membrane marker horseradish peroxidase (aHRP),
and the cell adhesion molecule Fasciclin II (aFasII). The
localization of Sdc is quite specific to the synapse,
with little or no protein detected along motor axons or
branches that are free of boutons (Figures 1C and 1D),
despite abundant accumulation along motor axons at
early stages of development (Johnson et al., 2004). To
confirm the specificity of the Sdc staining at the NMJ,
we examined Sdc mutant larvae (Sdcl(2)10608/Df[2R]48,
ubi-sara; see Experimental Procedures) and no Sdc sig-
nal was detected (Figure 1E).
Inspection of wild-type NMJs revealed that Sdc stain-
ing extends in a halo-like distribution around type Ib and
Is boutons (Figures 1D and 1I). This pattern indicates
that the majority of synaptic Sdc is found either on the
muscle surface or in the space between the presynaptic
membrane and the subsynaptic reticulum (SSR) (see
Figure 1B). To examine Sdc distribution more thoroughly,
we performed line scans of fluorescence intensity com-
paring the Sdc signal to that of the HRP epitope (Figure 1J).
Although Sdc and HRP show some overlap, most of the
Sdc surrounds the bouton. Sdc is absent from type II
boutons that lack SSR structures (e.g., on muscles 12
and 13; Figure 1H).
Although anti-Dlp antibodies have been used to char-
acterize Dlp localization during epitheilial patterning and
axon guidance (Johnson et al., 2004; Kirkpatrick et al.,
2004; Rawson et al., 2005), the synaptic localization of
glypicans have not been described in any organism.
The localization of Dlp and Sdc overlapped at the NMJ
(Figure 1F). Like Sdc, very little Dlp was found along
motor axons or bouton-free regions of the presynaptic
arbor. Careful examination revealed that Dlp accumu-
lates in punctate structures that are contained within a
broader distribution of Sdc (Figure 1G, arrowheads),
suggesting that Dlp is restricted to a subset of synaptic
space.
Syndecan Is Required to Promote Normal
Synapse Growth
Given the synaptic localization of Sdc and Dlp, we won-
dered if they might be required for some aspect of syn-
aptogenesis. After first ruling out defects in embryonic
motor axon guidance in both Sdc and Dlp zygoticloss-of-function (LOF) mutants (see Supplemental
Data), we examined larval NMJs with several anatomical
markers. Using the presynaptic markers HRP and
MAP1b/Futsch, we compared several wild-type strains
with mutants lacking Sdc or Dlp. No gross defects in
the branched structure of presynaptic terminals were
observed (Figures 2A–2C). For a more detailed view of
synapse structure, we examined a series of additional
markers, including the presynaptic active zone antigen
NC82, the SSR marker Dlg, and glutamate receptors
(GluRIII) that cluster on the postsynaptic membrane.
No obvious defects in the levels or distribution of these
markers were observed in Sdcmutants (Figures 2D–2G).
We also found no defects in levels or localization of the
synaptic vesicle markers Synaptotagmin (Syt) and Cys-
teine-string protein (CSP), or the endocytic marker
Endophillin (not shown). Similar results were obtained
for Dlp mutants with HRP, Futsch, FasII, NC82, GluRIII,
Sdc, and LAR as markers (not shown).
Although we found no alteration in the distributions of
synaptic marker proteins in Sdc mutants, we did dis-
cover a defect in synaptic growth. At the crawling third
instar stage, wild-type NMJs contain a stereotyped,
segment-specific number of boutons reflecting the
steady growth of the synapse over larval life. When we
quantified bouton number at NMJs formed on muscles
7 and 6 in a wild-type strain (Canton S) and in different
Sdc alleles, we found a highly significant reduction in
bouton number (over 35% in Sdcl(2)10608/Df48,ubi-Sara,
p < 1028) (Figure 2H, triple asterisk); comparable pheno-
types were observed at abdominal segments A2 and A3
(not shown). When wild-type was compared to a control
genotype with normal levels of Sdc and a genetic back-
ground identical to the Sdc mutant strain, no significant
difference was found (P12357/P12345) (Figure 2H). We
used mitotic recombination as an additional control for
genetic background effects to remove flanking polymor-
phisms from the Sdc chromosome, and the NMJ pheno-
type of the recombinant was not significantly less severe
than the original Sdc mutant (p = 0.2) (Figure 2H). To be
certain that this Sdc phenotype did not reflect reduction
in the overall growth of Sdc mutant tissues, we com-
pared the size of muscles 6 and 7 in mutants and con-
trols but found no significant difference (mean muscle
areas were 79698 mm2 in wild-type compared to 78702
mm2 in Sdc mutants; p = 0.8). Thus, we concluded that
Sdc is required for the normal addition of boutons
throughout NMJ growth.
We next asked if we could rescue theSdcNMJ pheno-
type with a cDNA transgene under the control of a tis-
sue-specific GAL4 driver. We found that expression of
an Sdc construct under control of a presynaptic driver
(elav-GAL4) provided nearly complete rescue of the
NMJ growth defect (p < 1024) (Figure 2H, double aster-
isk). The localization of the UAS-Sdc transgenic protein
(driven by elav-GAL4 in an Sdc LOF background) was in-
distinguishable from the pattern of endogenous Sdc in
wild-type (Figure 2J). When we used a postsynaptic
driver (24B-GAL4) to express the same UAS-Sdc trans-
gene, we found only a very weak rescue activity
(15.5% recovery) (Figure 2H, single asterisk), suggesting
that Sdc acts primarily on the presynaptic membrane.
As a test of Sdc specificity at the NMJ, we examined
synapses lacking Dlp. Interestingly, the number of
Neuron
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(A–C) Confocal z projections of the 6/7 cleft in wild-type (A), a SdcP/Df48,ubi-sara mutant (B), and a dlp1/dlp2 mutant (C) from larvae stained with
anti-HRP and anti-Futsch show no gross defects in the overall NMJ structure.
(D and E) SdcP/Df48,ubi-sara mutant NMJs (E) exhibit no obvious defects in NC82-antigen or GluRIII expression or in GluRIII clustering around
NC82-positive active zones, compared to wild-type (D).
(F and G) The distrubution of the SSR marker Dlg also appeared normal in SdcP/Df48,ubi-sara mutant NMJs (G) compared to wild-type (F).
(H) Quantification of bouton numbers per 6/7 NMJ (segment A2) shows thatSdcP2377/SdcP2377,Sdcl(2)10608/Df48,ubi-saramutants (p = 9.53 1029;
triple asterisk) or a recombinantSdc chromosome (SdcP recomb/Df48,ubi-saramutants) have significantly fewer boutons compared to Canton S
or a genetically matched wild-type control (P12357/P12345). Presynaptic expression of UAS-Sdc rescues the bouton reduction phenotype
(p = 2.3 3 1025; double asterisk), whereas postsynaptic expression provides only limited rescue (single asterisk). UAS-Dlp is unable to rescue the
Sdc phenotype, and mutations in dallylike (dlp1/dlp2) do not cause a significant reduction in bouton number. Blue bar represents SEM of Canton
S, and pink bar represents SEM of SdcP/Df48,ubisara.
(I and J) Sdc distribution in an Sdc mutant expressing UAS-Sdc under a neuron-specific elav-GAL4 source ([K], also used for rescue in [H]) is
equivalent to wild-type (J).
(K and L) Elevated expression of UAS-Sdc (GOF) in wild-type larvae under either presynaptic elav-GAL4 (L) or postsynaptic 24B-GAL4 both in-
duce a significant percentage increase in bouton number compared to GAL4 alone (blue bars represent SEMs of GAL4 alone control values).
Scale bar represents approximately 50 mm in (A)–(C), 4 mm in (D)–(G), and 2 mm in (J) and (K).boutons in the dlp mutant were within normal range
(Figure 2H). In the embryonic CNS, we previously found
that elevation of Dlp expression can rescue some of the
midline axon guidance defects seen in Sdc mutants(Johnson et al., 2004), suggesting functional redun-
dancy between the two HSPGs. As a further test of spec-
ificity at the synapse, we expressed wild-type Dlp in the
Sdc mutant but found no rescue of the growth defect
HSPGs Bind LAR and Control Synapse Growth
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Sdc phenotype, suggesting that there might be an an-
tagonistic relationship between the two HSPGs. Thus,
in the context of synapse growth, Sdc function appears
to be highly specific compared to Dlp.
In cell culture, elevated expression of vertebrate Syn-
decan-2 can accelerate the maturation of glutamatergic
synapses (Ethell and Yamaguchi, 1999), suggesting that
HSPG levels may be instructive for synapse growth. To
ask if Sdc can achieve this effect in vivo, we tested
whether Sdc is limiting for NMJ growth in Drosophila.
Using GAL4 drivers specific to neurons or muscle cells,
we misexpressed Sdc in a wild-type background. Pre-
synaptic elevation of Sdc increased bouton number
compared to GAL4 alone (p < 0.001) (Figure 2K). Inter-
estingly, despite the poor rescue activity of postsynap-
tic Sdc, muscle expression of Sdc in a wild-type back-
ground gave a similar increase in synapse size (p <
0.001) (Figure 2K). This gain-of-function (GOF) pheno-
type was the opposite of that observed in the Sdc
LOF, demonstrating that Sdc is limiting for synapse
growth.
Dallylike Regulates Synaptic Transmission
and Active Zone Morphology
Cell surface HSPGs have been implicated as regulators
of synaptic function by gross enzymatic depletion of HS
(e.g., Lauri et al. [1999]). To test if specific HSPGs are in-
deed required for normal synapse physiology, we mea-
sured the excitatory junctional potential (EJP) elicited by
stimulation of the intersegmental motor nerve trunk in
crawling third instar larvae at 1.0 mM extracellular
Ca2+, comparing a wild-type strain (Oregon R, OR) to a
strong Sdc LOF genotype (Sdcl(2)10608/Df[2R]48,ubi-sara)
(Figures 3A and 3B). Compared to controls, Sdc mutant
EJPs were not significantly reduced (p = 0.9) (Figures
3A, 3B, and 3D). We also measured the amplitude and
frequency of spontaneous release events (miniature
events; mEJPs); although there seemed to be a slight de-
crease relative to OR, it was not statistically significant
(p = 0.8 and 0.6, respectively) (Figures 3E and 3F). This
suggests that Sdc mutant NMJs accomplish some type
of functional compensation for their decreased overall
size.
We next examined the physiology of dlp mutants.
Here, we found a significant increase in EJP amplitude
(45% higher than OR in dlp1/dlp2, p = 0.0001) (Figures
3C and 3D), without a significant change in muscle input
resistance. Comparable EJP amplitudes were seen
when the dlp1 allele was examined over a deletion at
the locus (not shown). To confirm that loss of Dlp alone
induced the change in EJP amplitude, we also per-
formed a rescue experiment with a full-length wild-
type UAS-Dlp transgene; the wild-type Dlp transgene
restored EJP values to normal levels (UAS-Dlp[+];dlp1/
dlp2 EJPs were 32.4 mV [n = 9] compared to 32.5 mV
observed in OR [n = 8]; p = 0.98). Similar to Dlp function
during axon guidance (Rawson et al., 2005), GAL4 activ-
ity was not required to achieve full rescue of the dlp syn-
apse phenotype, suggesting that very small quantities of
Dlp are sufficient to restore synaptic function.
Thedlp neurotransmission phenotype could reflect in-
creased glutamate release or elevated postsynaptic
sensitivity. To distinguish between these possibilities,we analyzed mEJPs. The mean amplitude of dlp mutant
mEJPs was not significantly different from wild-type (p =
0.2) (Figure 3E). The frequency of mEJPs was also nor-
mal in dlp mutants (p = 0.5) (Figure 3F), suggesting
that the defect was specific to the evoked release mech-
anism. To compare the number of glutamate quanta re-
leased with each presynaptic stimulus, we calculated
quantal content values with mEJP amplitude to deter-
mine quantal size correcting for nonlinear summation
and found a significant increase in dlp mutants relative
to wild-type (64%, p = 0.0002) (Figure 3G). Thus, in con-
trast to Sdc, Dlp is required for normal synapse physiol-
ogy, acting to restrict the number of quanta released per
stimulus.
Neurotransmitter release is orchestrated at special
sites on the presynaptic membrane called active zones
(AZs) that can be visualized at an ultrastructural level.
We asked if there might be a morphological correlate
to the functional defects observed in dlp mutants. Serial
section transmission electron microscopy (EM) was per-
formed for dlp, Sdc, and a wild-type strain; multiple type
Ib boutons from several animals were examined for each
genotype. We found no gross alteration in overall NMJ
structure. Key structures such as the subsynaptic retic-
ulum (SSR), synaptic vesicles, AZs, and t bars were
present in both HSPG mutants (Figures 3H–3P).
To obtain a quantitative metric of AZ structure, we
measured the dimensions of AZs in the HSPG mutants.
In Sdc mutants, there was no significant change in AZ
area relative to controls (p = 0.7) (Figure 3Q), consistent
with the absence of a physiological phenotype. How-
ever, dlp mutant AZs were significantly smaller than
wild-type or Sdc (p = 0.02) (Figure 3Q). A decrease in
AZ area alone could not explain the increased quantal
context in dlp mutants, so we counted the number of
AZs per bouton and found that although Sdc mutants
are not significantly different from control, dlp mutants
show a roughly 2-fold increase in AZ density (Figure 3R).
Finally, we asked if Dlp is limiting for AZ morphogenesis.
EM reconstruction after postsynaptic elevation of UAS-
Dlp revealed a nearly 2-fold increase in AZ area, pre-
cisely the opposite of dlp loss of function (Figure 3S).
Together with our analysis of NMJ growth, the physio-
logical and ultrastructural data reveal striking specificity
in HSPG action at the synapse, with Sdc controlling NMJ
growth and Dlp controlling AZ morphogenesis.
Sdc and Dlp Bind to LAR
Among candidate receptors that might mediate the syn-
aptic effects of HSPGs, the LAR family of receptor pro-
tein tyrosine phosphatases (RPTPs) was particularly at-
tractive because the LAR ortholog PTP-s binds to two
vertebrate proteoglycans, Agrin and Collagen XVIII (Ari-
cescu et al., 2002), and LAR is required for synapse
growth as well active zone form and function in Dro-
sophila (Kaufmann et al., 2002). Moreover, while this
manuscript was in review, binding between LAR and
Sdc was described in the Drosophila embryo (K. Zinn,
personal communication; Fox and Zinn, 2005).
To test for a cell-surface interaction between LAR and
Sdc, we constructed a fusion protein with the Drosoph-
ila Sdc extracellular (EC) domain linked to an alkaline
phosphatase (AP) tag and used it to probe Drosophila
S2 cells expressing a cDNA encoding an epitope-tagged
Neuron
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(A–C) Evoked EPSPs recorded in muscle 6 of wild-type (A), Sdc (Sdcl(2)10608/Df[2R]48, ubi-sara, [B]), and dlp (dlp1/dlp2, [C]) genotypes show that
dlp mutants have increased responses to identical stimuli (see Experimental Procedures).
(D) Quantitative histograms show that dlp mutant EPSPs are 35% higher than Oregon R or Sdc mutants (p = 0.001, asterisk).
(E and F) Histograms compare miniature EPSP amplitude (E) and frequency (F); these differences are not statistically significant (see text).
(G) Calculation of quantal content values (corrected for nonlinear summation) for Oregon R (wt), SdcP/Df48,ubi-sara, and dlp1/dlp2 reveals
a highly significant increase in dlp mutants (45%, p = 0.0001; double asterisk). Uncorrected values for Oregon R, SdcP/Df48,ubi-sara, and
dlp1/dlp2 are 30.40 + 1.61 (SEM), 32.40 + 4.76 (p = 0.7), and 42.84 + 1.91 (p = 0.0002).
(H–J) Transmission electron micrographs of wild-type, SdcP/Df48,ubi-sara, and dlp1/dlp2 mutants show no gross ultrastructural morphology de-
fects. Type 1b presynaptic boutons are surrounded by subsynaptic reticulum muscle membranes (SSR) and contain characteristic membranous
organelles and vesicles. One active zone (with t bar) is marked in each micrograph with an asterisk. Inset in (H) shows a higher magnification view
of a presynaptic mitochondrion as an indication of the quality of fixation and osmotic balance.
(K–M) Intermediate magnification of the presynaptic membrane shows multiple active zones (AZ) in the same genotypes. Arrowheads mark the
AZ boundaries and t bar structures are marked with asterisks.
(N–P) High magnification views of AZs in the three genotypes reveal characteristic t bar structures (arrows) and proximal vesicle accumulations.
(Q) Bar graphs of mean AZ areas measured from serial reconstructions in wild-type, Sdc, and dlp mutants show a significant decrease in dlp mu-
tants (p = 0.02; asterisk). The number of active zones reconstructed for each genotype were wild-type (n = 19), Sdcl(2)10608/Df(2R)48,ubi-sara
(n = 21), and dlp1/dlp2 (n = 42). The number of boutons reconstructed for this analysis was: wild-type (n = 5), Sdcl(2)10608/Df(2R)48,ubi-sara
(n = 6), and dlp1/dlp2 (n = 11).
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LAR
(A) Quantification of Sdc-AP or Dlp-AP bind-
ing to LAR-transfected cells. Sdc-AP or Dlp-
AP probes, or an AP control, were tested for
binding to Drosophila S2 cells transfected
with LARDP-FLAG, a variant with the phos-
phatase domains deleted to avoid reduced
cell viability, or to control cells transfected
with empty vector. Both Dlp-AP and Sdc-AP
showed little binding to control S2 cells and
much stronger binding to cells transfected
with the LAR construct LARDP-FLAG (p <
0.0001). Dlp-AP bound to LAR transfected
cells at higher levels than did Sdc-AP (p <
0.001). Bars represent mean 6 SEM; per-
formed in triplicate.
(B) Sdc-AP and Dlp-AP binding to LAR-trans-
fected cells detected by in situ staining. Both
Sdc-AP and Dlp-AP bound to LAR-trans-
fected cells and showed cell-surface staining
not seen in controls. Dlp-AP stained more
cells with greater intensity than Sdc-AP. All
images 203 magnification; top row are
brightfield, and bottom row are DIC images.
(C) Western blotting (IB) of recombinant pro-
teins. Left: AP fusion proteins detected by
IB for a C-terminal myc tag. Sdc-AP appears
as approximately 90 kDa, with a smear ex-
tending up to the wells (presumably HS-mod-
ified Sdc-AP). In contrast, ST3-AP, an Sdc
variant with the HS attachment sites mutated,
migrates as a single band at 90 kDa, without
the higher molecular weight species, consis-
tent with a lack of HS. Similar to Sdc-AP, Dlp-
AP migrates as a smear from its calculated
137 kDa. Control unfused AP (approximately 67 kDa) is also shown. Middle: inducible LARDP-FLAG expression in transfected S2 cells. Mem-
brane fractions of uninduced and induced LAR-transfected cells were tested by IB for a C-terminal FLAG tag. The LARDP-FLAG protein is
detected as a band at the expected molecular weight. Right: expression of DLARec-Fc, DLARIg-Fc, or DLARFn-Fc detected at the expected
molecular weights by IB for the C-terminal Fc tag.LAR receptor (Figure 4C). Sdc-AP showed little binding
to untransfected S2 cells but bound strongly to cells
transfected with a LAR construct (p < 0.0001) (Figures
4A and 4B).
In view of this interaction between Sdc and LAR, we
wondered if LAR might also associate with Dlp. Like
Sdc-AP, Dlp-AP bound effectively to S2 cells in a LAR
dependent fashion. In fact, in both quantitative assays
(Figure 4A) and cell culture binding assays (Figure 4B),
Dlp-AP consistently bound to LAR-transfected cells to
a greater extent than did Sdc-AP (p < 0.001) (Figure 4A),
suggesting that LAR might have a greater affinity for Dlp
than for Sdc.
To confirm the binding of LAR with Sdc and Dlp in
a cell-free system and to characterize the interaction in
more detail, we used a quantitative in vitro protein bind-
ing assay in which Dlp-AP or Sdc-AP fusion proteins
were tested for binding to a LAR-Fc fusion protein.
Sdc-AP displayed saturable binding to LAR-Fc (Fig-
ure 5A). Scatchard analysis of the binding data revealed
a dissociation constant (KD) of approximately 13 nM for
Sdc-LAR binding (Figure 5B).To localize the binding region within LAR and within
Sdc, we analyzed mutant proteins. Deletion mutants of
LAR showed that Sdc associated specifically with the Ig
but not the FN domains of the LAR extracellular domain
(Figure 5E). A mutant Sdc-AP, in which all GAG attach-
ment serine residues have been changed to threonines
(ST3-AP), did not bind to LAR (Figure 5E). Moreover, hep-
aritinase treatment of Sdc-AP to remove HS chains also
abrogated LAR binding (Figure 5F). In contrast to verte-
brate PTP-d (Wang and Bixby, 1999), we were unable to
detect homotypic binding of the Drosophila LAR ectodo-
main to itself in this assay (not shown).
Like Sdc, Dlp-AP showed high-affinity, saturable
binding to recombinant LAR-Fc protein (Figure 5C)
with a KD of approximately 8 nM (Figure 5D). Interest-
ingly, the affinity of Dlp for LAR was about twice as
strong as that of Sdc in repeated experiments (Figure 5D
and data not shown). Thus, the difference between Sdc
and Dlp in the efficiency of their binding to the surface of
LAR-transfected cells (Figure 4) might be explained
solely by the difference between their KD values (Fig-
ure 5). Like Sdc, Dlp-AP binding to LAR-Fc was specific(R) A bar graph of the number of active zones per bouton reveals a substantial increase in dlp mutants.
(S) To test if Dlp is limiting for active zone dimensions, we used a postsynaptic GAL4 to express UAS-Dlp(+) in a wild-type background. 21 active
zones were reconstructed, revealing a 1.6-fold increase in active zone area (p = 0.009; asterisk). Scale bar represents 600 nm in (H)–(J), 150 nm in
(K)–(M), and 80 nm in (N)–(P).
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(A and B) Saturation binding and Scatchard analysis of Sdc-AP bind-
ing to LAR-Fc.
(C and D) Saturation binding and Scatchard analysis of Dlp-AP bind-
ing to LAR-Fc. In each case, binding was saturable and produced an
apparently linear Scatchard plot. The experiment shown gave KD
values of 12.8 nM and 7.8 nM for Sdc and Dlp respectively; similar
values were obtained in repeated experiments, with Dlp-AP repro-
ducibly showing a KD approximately half that of Sdc-AP.
(E) Domain analysis of Sdc-AP and Dlp-AP binding to LAR-Fc.
LARec-Fc, which includes the full LAR ectodomain, binds to Sdc-
AP or Dlp-AP, but not to ST3-AP, a variant with the HS attachment
sites mutated. Sdc-AP and Dlp-AP bound to LARIg-Fc, containing
the Ig-like domains, but not to LARFn-Fc, containing the fibronec-
tin-III type repeats. The HSPG binding domain therefore localizes
to the Ig domains of LAR, and binding by Sdc-AP is dependent on
HS chains.
(F) LAR binding by Sdc-AP and Dlp-AP is reduced by removal of HS
chains. AP fusion proteins were pretreated with heparitinase and
tested for LAR binding activity.to the Ig domains and was highly sensitive to heparinase
(Figures 5E and 5F).
Syndecan and LAR Act in a Common
Genetic Pathway
The synapse growth phenotype that we discovered in
Sdc mutants (Figure 2) is essentially identical to that ob-
served in LAR mutants (Kaufmann et al., 2002). In addi-
tion, we find overlap between Sdc and LAR surrounding
the presynaptic membrane (Figure 1H). These features,
together with the biochemical association of Sdc and
LAR (Figures 4 and 5), suggest that Sdc acts in the
LAR pathway. If Sdc function relies upon LAR activity,
we would predict that a reduction in LAR should en-
hance a weak Sdc phenotype. We introduced one null
allele of LAR (LAR5.5/+) into an Sdc hypomorphic back-
ground (SdcPKG/Df48,ubi-sara) and found that LAR/+
enhanced the NMJ growth defect of Sdc to a level ap-
proaching that of the LAR homozygote (Figure 6A).
A more stringent way to test if two genes act in the
same pathway is to compare their single and double ho-
mozygous phenotypes. If Sdc and LAR act in indepen-
dent parallel pathways, the two phenotypes should be
additive. However, if they act in the same pathway, the
double null should display the same phenotype as the
single null. We used genetic recombination to combine
null alleles of Sdc and LAR and found that the double
mutant is indistinguishable from the LAR null alone
(Figure 6B). Because Sdc is limiting for synapse growth
inDrosophila (Figures 2K and 2L), we could demonstrate
this in a complementary way by asking if LAR is abso-
lutely required for Sdc to promote the addition of new
boutons. We compared presynaptic elevation of Sdc
in a wild-type background to the same expression in a
LAR null background. Sdc gain of function in a LAR mu-
tant background was identical to LAR alone (Figure 6B),
showing that all of the Sdc growth-promoting activity is
dependent on LAR.
Dallylike Opposes LAR Function
Although the synaptic localization and high affinity bind-
ing of Dlp and LAR suggested that Dlp might act in the
LAR pathway, the active zone morphology and electro-
physiology phenotypes of dlp and LAR mutants are op-
posite (Figure 3) (Kaufmann et al., 2002). This suggested
that Dlp might act to antagonize synaptic LAR. If this
were true, we reasoned that overexpression of Dlp might
inhibit LAR function and thus phenocopy a LAR mutant.
Using UAS-Dlp, we found significant decreases in bou-
ton numbers with either presynaptic or postsynaptic
GAL4 drivers, although a much stronger effect was
seen from muscle expression (14% decrease with
elav-GAL4 compared to 30% decrease with 24B-
GAL4) (Figure 6D). Although this gain-of-function phe-
notype was similar to LAR LOF, satisfying our predic-
tion, we further reasoned that an instructive upstream
antagonist should be able to block the effect of LAR
overexpression. Indeed, although overexpression of
LAR alone increased bouton number, simultaneous ele-
vation of Dlp and LAR gave a phenotype the same as Dlp
alone (Figure 6E).
If LAR and Dlp were to act in separate parallel path-
ways, we would predict that Dlp overexpression com-
bined with a LAR null would have additive effects in
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(A–F) Double mutant assays score NMJ size in bouton number plotted as percentage change compared to a wild-type control. Green and red in
the vertical bars represents increase and decrease relative to controls, respectively. Blue and pink horizontal bars represent SEM in wild-type
and selected mutant, respectively. (A) Dose-dependent interaction between Sdc and LAR: a single allele of LAR (Dlar5.5/+) crossed into a Sdc
hypomorph (SdcPKG/Df48, ubi-sara) and compared to single mutants and LAR homozygotes for NMJ size. Reduction of LAR enhances the
weak Sdc phenoytpe. (B) A double loss-of-function mutant lacking both Sdc and LAR is not significantly different in bouton number than
a LAR null alone. (C) Presynaptic (elav-GAL4) elevation of UAS-Sdc increases bouton number relative to controls; however, Sdc displays no
gain-of-function activity when combined with a Dlar null genetic background. (D) Presynaptic (elav-GAL4) or postsynaptic (24B-GAL4) elevation
of UAS-Dlp induce a significant percentage decrease in bouton number at the A2 6/7 NMJ. (E) Using a combination of pre- and postsynaptic
drivers (scabrous-GAL4+24B-GAL4), we find that Dlp and LAR have opposing effects on bouton number and that combined expression of
Dlp and LAR decreases NMJ size. (F) Postsynaptic overexpression of Dlp causes a significant decrease in NMJ size, as does loss of LAR activity;
however, the combined effects of both perturbations (GOF+LOF) are not significantly different than loss of LAR alone.reducing NMJ size; however, if both genes function in
the same pathway, the combined phenotype should be
no stronger than the LAR null alone. We found the latter
to be true, with no significant difference between
LAR13.2/LAR5.5and LAR13.2/LAR5.5;24B-GAL4/UAS-Dlp
(Figure 6F). Together, these gain-of-function assays
support the hypothesis that Dlp antagonizes LAR
in vivo.
Dallylike Acts Uptream of LAR to Regulate
Tyrosine Phosphorylation
A direct way to show that Dlp regulates LAR receptor
signaling activity is to assay the activation state of
downstream effector proteins. In our previous analysis
of LAR signaling, we discovered that the phosphopro-
tein Enabled (Ena): (1) displays a LAR-like axon pheno-
type, (2) binds directly to the LAR cytoplasmic domain,
and (3) can be dephosphorylated by LAR (Wills et al.,
1999). Our previous assays for LAR catalysis were per-
formed in vitro, and so we wanted additional confirma-
tion that Ena interacts with the LAR catalytic active
site in an intact cell. For this purpose, we constructed
active site point mutations that allow PTPs to bind phos-
phorylated substrates and initiate the first step of catal-
ysis but then fail to release the bound substrate (‘‘sub-
strate trap’’) (Garton et al., 1996). Using wild-type andsubstrate trapping mutations (D-A in D1 and D2 PTP do-
mains) in epitope-tagged LAR catalytic domains, we
asked if endogenous Ena in Drosophila S2 or KC167
cells binds preferentially to either construct. As assayed
by affinity purification and Western blot, Ena bound to
the wild-type LAR PTP domains, with no binding to the
tag alone (Figure 7A). However, the LAR substrate trap
bound far more effectively to Ena under identical condi-
tions (Figure 7A), supporting our previous genetic hy-
pothesis that Ena is a physiological LAR substrate.
To provide a functional assay for LAR activity, we then
used RNA interference (RNAi) in Drosophila KC167 cells
followed by immunoprecipitation of endogenous Ena
(Figure 7B). When we knocked down endogenous LAR
and then assayed Ena by anti-phospho-tyrosine (p-
Tyr) Western blot, we found a reproducible increase in
Ena phosphorylation (p = 0.016) (Figures 7B and 7C),
as predicted from our substrate-trapping data. When
we used RNAi to reduce endogenous Dlp expression,
we found the opposite effect on Ena phosphorylation
(p = 0.002) (Figures 7B and 7C), consistent with a model
in which Dlp acts to inhibit LAR activity. To test if Dlp
acts upstream in a LAR-dependent fashion, we per-
formed a double-RNAi of both proteins. Here, we found
that the LAR phenotype was epistatic to Dlp (Figures 7B
and 7C). This last experiment demonstrates that Dlp
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Effects on Ena Phosphorylation
(A) Expression of epitope-tagged Drosophila
LAR cytoplasmic domain constructs (Dlar
D1+D2 PTP) in S2 cells followed by purifica-
tion of either the tag alone, wild-type LAR
(Dlar [+]), or a dual substrate trapping muta-
tion in both PTP domains D1 and D2
(Dlar[D-A]) was used in combination with
Western blot (IB) with anti-Drosophila Ena to
assay for relative levels of Ena-LAR associa-
tion. Endogenous Ena bound far more effec-
tively to the LAR substrate trapping mutant.
Parallel experiments were performed in
KC167 cells with similar results.
(B) Drosophila KC167 cells were used for
RNA interference targeting GFP (as a control),
Dlar, and/or Dlp. Subsequent immunoprecip-
itation (IP) of endogenous Ena followed by
Western blot (IB) with either anti-phospho-
tyrosine (p-Tyr) or anti-Ena (to normalize) as-
sayed Ena phosphorylation. Control IB data
are shown to document the level of Dlar and
Dlp.
(C) Quantification of gel-band density from (B)
shows the percentage change in Ena tyrosine
phosphorylation compared to untreated con-
trols after knock down of Dlar, Dlp, or both
proteins (single asterisk, p = 0.016; double
asterisk, p = 0.002; triple asterisk, p = 0.023).
(D) To assess the activity of Drosophila LAR
(Dlar) UAS-cDNA transgenes during NMJ
growth, we compared LAR null mutants
(Dlar13.2/Dlar5.5) to a wild-type control (Can-
ton S) and to lines expressing GAL4 in this
background. Although neither GAL4 alone
nor postsynaptic expression of a full-length,
wild-type LAR (Dlar [+]) rescued the A2 6/7
NMJ phenotype, presynaptic LAR expression
restored the mutant NMJ (asterisk). When
transgenes lacking either the FN domains
2–9 (DFN), Ig domain 1–3 (DIg), or the two cat-
alytic cysteine residues in PTP domains D1
and D2 (2xC-S) were assayed with elav-
GAL4, only UAS-DlarDFN provided signifi-
cant rescue activity (p = 0.017; double aster-
isk).acts upstream of LAR, supporting a model in which
Dlp regulates Ena phosphorylation via inhibition of LAR
activity.
Ig Domains and Catalytic Activity Are Essential
for Synaptic LAR
A model in which Sdc and Dlp regulate LAR activity
through direct binding would predict that the Ig domainsand catalytic activity of the receptor be necessary for
NMJ development. However, in a recent analysis of
LAR domains required for rescue of lethality, we found
that neither of these conserved features were absolutely
required (Krueger et al., 2003). Thus, we wanted to re-
examine this question in the context of the NMJ. Before
testing different LARmutant trangenes, we asked where
full-length, wild-type LAR must be expressed to rescue
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(A) Competition between Sdc and Dlp fusion proteins for binding to
LAR in vitro. Sdc-AP was tested for binding to LAR-Fc, in the pres-
ence or absence of competing fusion proteins Dlp-APSA (red line) or
Sdc-APSA (green line). The observed Bmax (maximal binding) of
SdcAP to LAR was similar in each case (43.6, 41.8, and 42.3 mOD/
min, respectively, in the presence of Dlp-APSA, Sdc-APSA, and con-
trol), indicative of competitive rather than noncompetitive binding
inhibition. Dlp-APSA reproducibly showed a Ki lower than that of
Sdc-APSA; the experiment shown here gave Ki values of approxi-
mately 25 nM and 17 nM for Sdc-APSA and Dlp-APSA, respectively,
with similar values obtained in repeated experiments.
(B) Bouton number was quantified and plotted as percentage
change relative to control in larvae overexpressing either Sdc, Dlp,
or both under control of 24B-GAL4 to determine which HSPG is
dominant in vivo. UAS-Dlp alone was indistinguishable from UAS-
Dlp+UAS-Sdc. Light green, blue, and pink horizontal bars represent
SEM for UAS-Sdc, 24B-GAL4 control, and UAS-Dlp+UAS-Sdc, re-
spectively.
(C) Based on genetic data, LAR functions presynaptically to link bou-
ton growth and active zone formation. Sdc (green) functions witha LAR null NMJ phenotype (see Experimental Proce-
dures). Although muscle expression of UAS-LAR(+)
with the GAL4 driver 24B did not rescue the LAR mutant
phenotype, neuron-specific expression with elav-GAL4
restored LAR NMJs to normal size (Figure 7D, double
asterisk). We then expressed three mutant transgenes
of LAR under the same elav-GAL4 driver in the null back-
ground: DIg (removing all three Ig domains), DFN (re-
moving FN repeats 2–9), and 23C-S (eliminating cata-
lytic activity in both PTP domains). However, at the
NMJ only DFN provided any significant rescue activity
compared to the LAR null alone (p = 0.017) (Figure 7D,
single asterisk), demonstrating that LAR Ig domains
and PTP catalysis are essential for synapse growth, as
predicted by the biochemical and genetic data linking
Sdc and Dlp to LAR function.
HSPG Competition for LAR Binding
and Synapse Growth
Multiple experiments suggest that Sdc and Dlp exert
opposing effects on LAR during synapse development.
Because Sdc and Dlp are both present at the NMJ,
this raised questions of whether the two HSPGs com-
pete for access to LAR and which HSPG is dominant
for binding and biological activity.
We first asked if the HSPGs can effectively compete
with each other for binding to the LAR receptor. To pro-
duce a generally applicable vector for use in competition
binding experiments with AP-tagged proteins, we con-
structed a version of the AP tag lacking catalytic activity.
This construct was produced from the APtag-5 vector
(Flanagan et al., 2000) by mutating Ser109 at the enzyme
active site to Alanine, producing vector APtag-5SA.
Competition binding experiments were then performed
by quantifying the bound AP activity after treating immo-
bilized Fc-tagged LAR with AP-tagged HSPG, in the
presence or absence of competing APSA-tagged pro-
teins. The results show that Sdc and Dlp fusion proteins
can compete with one another for binding to LAR-Fc
(Figure 8A). Dlp-APSA gave more effective inhibition of
binding, with a Ki value lower than that of Sdc-AP
SA (Fig-
ure 8A). The observed Bmax (maximal amount bound)
for SdcAP was similar in the presence or absence of
Sdc-APSA or Dlp-APSA, indicative of competitive rather
than noncompetitive binding inhibition (Figure 8A and
legend). A simple molecular interpretation would be
that Sdc and Dlp bind to identical or overlapping binding
sites on LAR.
Having shown that Sdc and Dlp compete for LAR
binding in vitro and display opposite gain-of-function
phenotypes during synapse development in vivo, we
then asked if simultaneous elevation of the two genes
would reveal which HSPG is dominant in vivo. Thus,
we simultaneously elevated both Sdc and Dlp under
a single GAL4 driver in a wild-type background and
compared the outcome to expression of the single
LAR to promote bouton growth (1), a function dependent on LAR
catalytic activity. Dlp (red) inhibits LAR activity (2) and is required
to regulate active zone formation, presumably by blocking growth
signals in favor of other effectors. Biochemical and genetic data sug-
gest that Dlp has a competitive advantage. This leads to a model in
which LAR mediates a natural transition between synapse growth
and active zone assembly (step 1 to step 2).
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pression of Sdc and Dlp was indistinguishable from ex-
pression of Dlp alone (Figure 8B). This demonstrates
that Dlp is completely dominant in vivo, consistent
with the competitive advantage of Dlp over Sdc for
LAR binding in vitro.
Discussion
Converging lines of evidence suggest that membrane-
associated HSPGs serve an important purpose in the
assembly, function and plasticity of excitatory synapses
(reviewed by Van Vactor et al. [2006] and Yamaguchi
[2001]). Here, we demonstrate that the ancient HSPG
families of syndecans and glypicans are necessary for
Drosophila to regulate distinct aspects of synaptic mor-
phogenesis. Moreover, our genetic and biochemical
data indicate that Sdc and Dlp interact with a shared re-
ceptor (LAR) to control presynaptic properties. Because
LAR-family RPTPs have been shown to control the for-
mation of excitatory synapses in Drosophila, C. elegans,
and mammals (Ackley et al., 2005; Dunah et al., 2005;
Kaufmann et al., 2002), our findings may represent
a more general mechanism for regulating synaptic mor-
phogenesis and function. Despite the importance of
LAR-family RPTPs during cellular morphogenesis inside
and outside of the nervous system (reviewed by John-
son and Van Vactor [2003]), the lack of physiologically
relevant extracellular binding partners has made it chal-
lenging to study this well-conserved group of receptors.
Syndecan and LAR Promote Synaptic Growth
Our data show that Sdc promotes the formation of pre-
synaptic boutons. This Sdc function appears to be me-
diated by LAR, as supported by parallel phenotypes, di-
rect binding, in vivo colocalization, and three types of
double mutant analysis between Sdc and LAR. Despite
the fact that Sdc exhibits gain-of-function activity and
endogenous expression on both sides of the synapse,
our neuronal and muscle-specific rescue experiments
show that Sdc function is mainly presynaptic. Because
LAR is required only in neurons to promote synapse
growth, our findings support a model in which Sdc
acts as a neuronal cell-autonomous agonist of LAR.
This is somewhat surprising, given the fact that soluble
forms of Sdc bind to LAR and that endogenous Sdc ap-
pears to be released from the presynaptic membrane to
fill the SSR. One way for Sdc to act presynaptically
would be to bind to LAR even before the two proteins
are presented on the neuronal surface. Because Dlp
has a competitive advantage over Sdc for binding to
LAR, a prebound complex of Sdc and LAR would have
the ability to stimulate synapse growth before the phos-
phatase could be inhibited by Dlp. Such a mechanism
could provide a time- and/or HSPG concentration-
dependent switch from bouton addition to active zone
assembly (Figure 8C).
Sdc could promote LAR activity in collaboration with
an additional cell-type-specific membrane protein.
Data from a parallel study also identified Sdc-LAR inter-
actions during embryonic motor axon guidance (Fox
and Zinn, 2005). However, in contrast to CNS pathfind-
ing (Johnson et al., 2004; Steigemann et al., 2004), com-
plete loss of Sdc alone has no significant effect on motorpathfinding (Fox and Zinn, 2005; this study), suggesting
that additional LAR ligands exist in the early embryo.
Recent experiments with the vertebrate LAR ortholog
PTP-s suggest that non-HSPG ligands may regulate
its ability to promote retinal axon outgrowth (Sajnani
et al., 2005). Although it remains a formal possibility,
an additional ligand may not be needed to account for
the NMJ growth-promoting activity of LAR because
the larval synaptic phenotype in Sdc mutants is nearly
as strong as the growth defect in LAR mutants (Figure 2)
(Kaufmann et al., 2002).
Dallylike and LAR Interact to Control Active Zone
Form and Function
Active zone assembly is vital for neurotransmission at
the synapse and has been proposed as a means to mod-
ulate synaptic function over time (reviewed by Zhai and
Bellen [2004]). Our analysis of Dlp reveals that synaptic
glypicans are required to regulate active zone morphol-
ogy and function. Moreover, we find that Dlp is limiting
for active zone morphogenesis, consistent with an in-
structive role. Because the activities of Dlp appear op-
posite to those of LAR, we propose that the high affinity
binding of Dlp to LAR induces an inhibition of receptor
function (Figure 8C). This hypothesis is supported by
the double RNAi experiments showing that the LAR ef-
fect on Ena phosphorylation is epistatic to the effect of
Dlp, indicating that Dlp acts upstream of LAR. Because
loss of Dlp at the NMJ did not induce a significant
change in the number of presynaptic boutons, the re-
sults lead to a model in which Dlp is specialized for con-
trol of active zone properties. Such a function might pro-
vide a means to independently regulate and spatially
distinguish LAR inhibition from LAR activation. In any
case, the presence of active zone phenotypes in dlp
but not in Sdc reveals specialization among synaptic
HSPGs.
LAR regulates both NMJ growth and active zone mor-
phogenesis (Kaufmann et al., 2002). Thus, LAR appears
to provide a link between two important synaptic prop-
erties that are regulated by different extracellular fac-
tors. A mechanism to couple bouton growth and active
zone formation would make sense because active zones
appear early in the nascent bouton (Zito et al., 1999). Be-
cause LAR catalytic activity is necessary for bouton ad-
dition, and yet LAR inhibition by Dlp appears necessary
for proper active zone formation, LAR’s role at the active
zone may be primarily structural. For example, LAR may
simply provide an anchorage point for synaptic compo-
nents like the scaffolding protein Liprin-a that regulates
active zone formation (e.g., Kaufmann et al. [2002]). Al-
ternatively, LAR may exist in distinct yet active signaling
states, one of which is dependent on PTP activity (pro-
moting synapse growth), and one of which is dependent
on recruitment of signaling molecules (controlling active
zone assembly). Because loss of Dlp or LAR has oppo-
site effects on quantal content at the NMJ, it is attractive
to speculate that the Dlp-LAR pathway normally pro-
vides a means to modulate the strength of neurotrans-
mission, either during NMJ growth or during synaptic
plasticity. LAR PTPs are required for normal physiology
and plasticity at mammalian hippocampal synapses
(Dunah et al., 2005; Uetani et al., 2000).
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Sdc and Dlp are both HSPGs that bind to LAR and thus
might be expected to act similarly, but our results show
that their functions are different. One way to account for
the specificity might be a difference in the effect of sol-
uble versus cell-surface HSPGs on LAR. Some ligand
molecules such as Ephrins function when clustered at
high density (e.g., on a membrane surface) but fail to ac-
tivate their receptors when presented in a soluble, mo-
nomeric form (reviewed by Flanagan and Vanderhae-
ghen [1998]). Another possibility could be that LAR
binding or signaling is differentially influenced by direct
protein-protein interactions with the Sdc versus Dlp
core proteins. The two HSPGs have very different core
structures; Sdc is a transmembrane molecule with HS
modification sites near the N terminus, whereas Dlp is
a GPI-anchored protein with HS sites proximal to the
membrane and a large disulphide bonded globular do-
main located more distally (reviewed by Bernfield et al.
[1999]). It may also be relevant that Dlp consistently
bound more effectively to LAR than Sdc, with KD mea-
surements in solution showing an affinity approximately
2-fold higher. These results suggest a competition
model in which Dlp displaces Sdc, possibly to favor
the stabilization of active zones after new growth at
the synapse. In this model, presynaptic growth would
be initially promoted by Sdc and would then be limited
or halted by Dlp binding after formation of close mem-
brane contact between the nerve and muscle. Such
a mechanism could insure a transition from growth to
synapse stabilization (Figure 8C) and could participate
in subsequent maintenance or plasticity of the synapse.
Of course other molecules influence synapse size,
and these might include coligands or coreceptors that
may bind to Sdc, Dlp, and/or LAR. Potential candidates
might include bone morphogenic protein (BMP), the
type II BMP receptor Wishful thinking (Wit), or the Wnt
ortholog Wingless (Wg), which have all been shown to
regulate NMJ morphology in Drosophila (Aberle et al.,
2002; Marques et al., 2002; McCabe et al., 2003; Packard
et al., 2002). However, in addition to significant pheno-
typic differences compared to the HSPGs, overexpres-
sion studies indicate that neither BMP nor Wg are limit-
ing for NMJ morphogenesis (Aberle et al., 2002; Packard
et al., 2002). In contrast, Sdc and Dlp are both limiting for
different aspects of synapse development, consistent
with an instructive role in this context. Consistent with
this notion, Syndecan-2 is sufficient to promote den-
dritic spine maturation during hippocampal synapto-
genesis in culture (Ethell and Yamaguchi, 1999). Al-
though vertebrate Syndecan-2 has yet to be tested at
the synapse by loss of function, the colocalization and
parallel biology of Synecan-2 and vertebrate LAR-family
receptors strongly suggest conservation in the regula-
tion of synaptic LAR (Dunah et al., 2005; Hsueh and
Sheng, 1999; Hsueh et al., 1998).
Conclusions
The genetic and biochemical studies described here
identify a partnership between HSPGs and LAR in Dro-
sophila NMJ development that sets precedents for (1)
the in vivo requirement for members of the syndecan
and glypican families in synapse growth and electro-
physiological function, (2) the specificity of HSPG func-tion at the synapse, with distinct actions of Sdc and Dlp,
and (3) biochemical identification of Sdc and Dlp as LAR
binding partners, plus genetic evidence to place them in
a pathway regulating biological function at the synapse.
Experimental Procedures
Genetics
Drosophila strains descrbed in Baeg et al. (2001), Han et al. (2004),
Johnson et al. (2004), Kaufmann et al. (2002), Kirkpatrick et al.
(2004), and Luo et al. (1994) were balanced over CyO-[actin-GFP],
whereas dlp alleles were balanced over Tm6B-[ubi-GFP].
Immunohistochemistry of Cells and Tissues
Wandering third instar larvae from sparsely populated bottles were
collected and dissected in Ca2+-free saline. Several antibodies
required a detergent-free protocol to visualize labeling at the NMJ,
including anti-Dlar (1:100; gift from H. Saito), anti-Sdc (1:250) (Spring
et al., 1994), and anti-Dlp (1:50) (Lum et al., 2003). Other antibodies
(anti-Futsch [1:50] [Roos et al., 2000], mAb GluRIII [1:5000; gift
from A. DiAntonio], anti-HRP [1:2000; Capell], anti-FasII [1:20] [Van
Vactor et al., 1993], NC82 [1:100; gift from A. Hofbauer], anti-Dlg
[1:1000; gift from V. Budnik], anti-Cysteine string protein [CSP;
1:1000], and anti-Synaptotagmin anti-Endophilin [Syt; 1:1000 and
1:500; gifts from H. Bellen]) were used as previously described
(Kaufmann et al., 2002). Statistical analysis of boutons per NMJ
was conducted in Excel by Student’s t-test. Confocal microscopy
was performed as described (Johnson et al., 2004).
Fusion Proteins and Binding Assays
AP fusion constructs were generated by inserting ectodomain se-
quences for Sdc or Dlp in APtag5 (Flanagan et al., 2000). Fc fusion
proteins were in the Ig2eco vector (Cheng and Flanagan, 2001),
and Fc fusion concentration was normalized by Western blot against
the human Fc tag (see below). LARDP-FLAG was generated by am-
plifying the ectodomain and transmembrane domains of LAR with
PCR and subcloning into pMTAV5His. The three serine attachment
sites were converted to threonine (ST3) to remove the glycosylation
sites on Syndecan. Ser109 of APtag-5 was changed to alanine by
PCR, generating APSA to create a catalytically-inactive AP for com-
petition experiments.
Cell-free binding assays were performed with Reacti-Bind Protein
A-coated microtitre plates (Pierce). Wells were blocked with HBAH
(Hank’s Buffered Saline Solution with 0.5 mg/ml BSA and 20 mM
Hepes 7.0) for 15 min. DLAR-Fc fusion protein conditioned media
(approximately 2 mg/ml) were allowed to bind to protein A for
1.5 hr, room temperature. Wells were then washed four times with
HBAH, treated with AP fusion-conditioned medium for 1.5 hr, and
then washed and assayed for bound AP activity as described (Flana-
gan et al., 2000). For heparitinase treatment, 200 ml of 30 nM AP fu-
sion protein was incubated with 5 mU heparitinase (Seikagaku) or
mock treated at 37ºC for 1 hr. The concentration of the ‘‘cold’’
HSPG-APSA fusion proteins used in competition binding experi-
ments was approximately 25 nM as determined by comparison of
HSPG-APSA and HSPG-AP conditioned media by Western blot.
Cell surface binding assays were performed as described (Flanagan
et al., 2000) by using S2 cells transfected with Fugene (Roche) and
grown in suspension or on ConA-treated coverslips.
Protein Sample Preparation, RNA Interference,
and Western Blotting
Transfected S2 cells were incubated in five volumes of hypotonic ly-
sis buffer (25 mM Tris 7.5, 1 mM DTT, 1 Complete protease inhibitor
tablet [Roche]) on ice for 10 min. Lysates were passed through a G27
syringe needle five times, and nuclei were pelleted (5000 RPM, 4ºC,
5 min). The supernatants (membrane fractions) were collected and
pelleted (12,000 RPM, 4ºC, 10 min). Pellets were resuspended in
200 ml 13 SDS/PAGE sample buffer.
For Western blot analysis of recombinant protein expression,
fusion-protein-conditioned media or S2 cell membrane fractions
were subjected to SDS/PAGE on a 9% gel, transferred to Hybond
N+ membrane (AP fusion proteins) or PVDF membrane (Fc fusion
proteins and S2 cell membrane fractions), and blocked in 4% milk/
Neuron
530TBST for 1 hr. Blots were incubated with primary antibodies over-
night at 4ºC, and diluted 1:1000 in 4%milk/TBST: anti-Myc (9E10,
Santa Cruz Biotech), anti-human Fc-HRP (Amersham), anti-FLAG
(M2 mouse monoclonal, Sigma). Myc/Flag blots were washed five
times in TBST and incubated with anti-mouse Fc-HRP (Amersham)
1:1000 in 4%milk/TBST 1 hr. Blots were washed five times in TBST
and detected with ECL Plus reagent (Amersham).
Tandem affinity purification (TAP) was modified from Veraksa et al.
(2005) (see Supplemental Data). RNA interference was modified
from Worby et al. (2001) (see Supplemental Data). On completion
of dsRNA treatment, cells were harvested, lysed (lysis buffer same
as that used in TAP experiments described above), and an aliquot
was used to assess the efficiency of the dsRNA treatment by elec-
trophoresis on a 4%–15% gradient gel and immunoblotting with
anti-Dlar (a kind gift of Kai Zinn, 1:100), anti-Dlp (DSHB, 1:1000), or
anti-tubulin (Sigma, 1:3000) antibodies. For better resolution of
Dlp, the lysate was treated with Heparinase III (Seikagaku) as de-
scribed in Lum et al., 2003.
Ena monoclonal 1G6.C10 antibody was covalently attached to
beads with the ProFound Coimmunoprecipitation kit (Pierce), fol-
lowed by immunoprecipitation from control and dsRNA-treated
Kc167 lysates described above by the manufacturer’s protocol.
After immunoprecipitation, samples were split in half, and electro-
phoretic separation on two 10% gels performed followed by immu-
noblotting with either the anti-Ena antibody or a cocktail (1:1 w/w) of
rabbit polyclonal anti-phosphotyrosine antibodies (Upstate [06-427]
and Chemicon [AB1599]) used at 2 mg/ml. Densitometric quantifica-
tion was performed with the ImageJ software. Nitrocellulose mem-
branes (Amersham) were used for all immunoblot experiment except
for those involving detection of Dlp in which Hybond N+ membrane
(Amersham) was used.
Electrophysiology
Electrophysiology was preformed on late third-instar larvae. Mutant
larvae were raised on agar grape plates along with their heterozy-
gous siblings and separated at early third instar. Larvae were dis-
sected in Ca2+-free HL-3 saline with the following ionic concentra-
tions (in mM): 70 NaCl, 5 KCl, 20 MgCl2, 10 NaHCO3, 5 trehalose,
115 sucrose, and 5 HEPES (pH 7.2) (Stewart et al., 1994). All record-
ings were measured in HL-3 saline containing 1 mM Ca2+. Sharp mi-
croelectrodes (15–30 MOhms) were filled with 3 M KCl and were
used to record membrane potentials from muscle six of abdominal
segments A3 or A4. Wide bore suction electrodes were used to stim-
ulate the segmental nerve, which was cut free from the ventral nerve
cord. Spontaneous events were recorded in the absence of stimuli.
Recordings were analyzed only if the resting membrane potential
was %256 mV. Muscle input resistance was measured for each
genotype and found to be similar to control. Data were collected
with a Digidata1322A and Axopatch 2A amplifier (Axon Instruments).
Evoked potentials were analyzed with Clampfit8.2 (Axon Instru-
ments), and spontaneous events were analyzed with MiniAnalysis6
software (Synaptosoft, Inc.). The average EJP amplitude was calcu-
lated from averages of 20–25 events per each NMJ. 200 events per
NMJ were averaged to calculate mini event amplitude while 3 min
of recorded minis were used to calculate the mini frequency. Quantal
content was corrected for nonlinear summation with the previously
published method (McLachlan and Martin, 1981).
Electron Microscopy
Ultrastructural analysis was performed with modifications from
(Kaufmann et al., 2002) (see Supplemental Data).
Supplemental Data
The Supplemental Data for this article can be found online at http://
www.neuron.org/cgi/content/full/49/4/517/DC1/.
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